Cabot (CBT) Stock: Buy, Sell, or Hold?
CBT - Cabot Corporation
$73.62
0.16 (0.22%)
▲
5d:
-2.45%
30d:
-3.88%
90d:
-17.82%
WAIT
LOW Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Nov 02, 2026
11d
Get Alerted When CBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CBT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CBT shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$107.92
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$67.01
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBT is currently trading at $73.62, which is considered oversold relative to its 30-day fair value range of $75.01 to $78.84. The stock's valuation (Forward PE: 10.5) is in line with its historical norms (11.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CBT is in a strong downtrend. The price is currently testing key support at $73.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $90.33 (+22.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBT is in a strong downtrend. The price is currently testing key support at $73.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $90.33 (+22.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$75.01 -
$78.84
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.7% below Wall St target ($90.33)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$75.01 -
$78.84
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$73.04
Resistance Level
$76.91
Current Trend
Strong Downtrend
Technical data as of
Oct 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.54
Wall Street Target
$90.33
(+22.7%)
Revenue Growth (YoY)
6.4%
Earnings Growth (YoY)
-93.7%
Profit Margin
5.2%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
10.5 vs 11.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$72.29
(-2%)
2-Year Target
$70.99
(-4%)
3-Year Target
$69.72
(-5%)
3-Yr Target (if PE normalizes)
(PE: 11→11)
$73.44
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 9.7%)
$183.24
(+149%)
Base:
(SPY PE: 10.5, Growth: 9.7%)
$97.22
(+32%)
Bear:
(PE: 9.0, Growth: 9.7%)
$82.63
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 20.81 | Current EPS (TTM): $3.53
Bull Case
$159.94
(+117%)
Analyst growth 97.9%, PE expands to 22.9
Base Case
$145.40
(+98%)
Market implied 97.9%, PE stable at 20.8
Bear Case
$49.95
(-32%)
Severe decline -20.0%, PE contracts to 17.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.5 to 11.1
Stabilization Target:
$77.56
(+5.3%)
PE Expansion Potential:
+5.3%
Share & Embed Analysis
Last updated: October 20, 2026 11:14 PM ET
Data refreshes hourly during market hours. Next update: 12:14 AM
Data refreshes hourly during market hours. Next update: 12:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
STRONG BUY
29 analysts |
$544 | 45 HOLD |
|
ECL
Ecolab Inc |
STRONG BUY
24 analysts |
$325 | 49 HOLD |
|
SHW
Sherwin-Williams Co |
BUY
29 analysts |
$383 | 47 HOLD |
|
PPG
PPG Industries Inc |
BUY
25 analysts |
$126 | 60 HOLD |
|
RPM
RPM International Inc |
STRONG BUY
16 analysts |
$124 | 61 BUY |
